top of page
GOLD-26-Website-Magazine-Page-Banners-2023.jpg

THE FEBRUARY ISSUE
OF GOLD IS HERE

Check out the new issue of GOLD! From the exodus of pharma marketers from Twitter to integrating artificial intelligence into medical affairs, this issue explores how the industry is evolving with changing environments for the benefit of customers and patients.

February 2023

Featuring insight from industry experts, this issue of GOLD reflects on pharma’s ambition to transform itself in the coming year and beyond, including insights from the NEXT Pharma Summit’s NEXT Normal event.

 Topics include:  

  • Removing bias from AI

  • Digital key opinion leaders

  • Generational differences in HCP conversations 

  • Neurological breakthroughs

  • A revealing conversation with Mina Makar, Senior Vice President, Global Cardiovascular, Renal and Metabolism, AstraZeneca

GOLD 26 Front Cover.jpg

December 2022 

Featuring insight from industry experts, this issue of GOLD reflects on the key issues the industry has faced in 2022, including insights from Reuters Pharma 2022 and FT Live’s Global Pharma and Biotech Summit.

 

Topics include: 

  • Health equity for transgender patients

  • Real-world data in rare diseases 

  • Generics and biosimilars  

  • An insightful conversation with John Wahba, Medical Head of the Global Digital Hub, GSK

GOLD-25-2022-Web.jpg

October 2022 

Featuring a host of insight from industry thought leaders, this issue covers the rise of alternative drug development models and treatments, the industry’s response to landmark legislation changes in the US, the rise and fall of biotech investment and much more.

 Topics include:  

  • Non-drug treatments 

  • AI in drug discovery 

  • Pharma’s response to Roe v. Wade   

  • A revealing conversation with Reshema Kemps-Polanco, Executive Vice President and US Head, Novartis Oncology

GOLD-24-Front-Cover.jpg

The GOLD archive

Click the navigation arrows to scroll through each of GOLD's past issues. Click on a cover to read the issue and download.

YOU MIGHT ALSO LIKE.. 

Patients

Mental health matters
in pharma’s approach
to care
Mental-health-matters.jpg

Treatments for cancer and other conditions are continuously advancing, but pharma must also focus on supporting patients’ mental health.

Innovation

The brains behind neurological breakthroughs
Neurological-breakthroughs.jpg

The recent FDA approval of lecanemab is a win for Alzheimer’s patients, but how can pharma ensure access?

News

Spotlight
 
Spotlight_typewriter_news.jpg

GOLD looks back at some of the pharma industry’s most recent news.

Never miss an update, subscribe! 

bottom of page